| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.9 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |